Insiders Updates Ascendiant Capital Markets initates Lucid Diagnostics Inc (LUCD) rating to a Buy Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.24 million on May
Stock Earnings Lucid Diagnostics Inc [LUCD] stock for 242,292 USD was acquired by Matheis Dennis Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lucid Diagnostics